Vancouver, Canada

Bertrand Mc Plouvier

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Cardiome Pharma Corp.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bertrand Mc Plouvier. Retrieved from https://idiyas.com/inventor/bertrand-mc-plouvier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Bertrand MC Plouvier

Introduction

Bertrand MC Plouvier, a notable inventor based in Vancouver, Canada, has made significant contributions to the field of chemical compounds. With a focus on innovative solutions, he remains dedicated to advancing research and development in the pharmaceutical industry.

Latest Patents

Bertrand holds one patent, which pertains to deuterated aminocyclohexyl ether compounds and processes for preparing these compounds. This invention opens new doors for various applications, expanding the potential utility of these unique chemical structures. The patent highlights methods of using these compounds, showcasing the innovative nature of Bertrand's work.

Career Highlights

Currently, Bertrand is associated with Cardiome Pharma Corp., a company known for its commitment to developing innovative therapeutic solutions. His role involves contributing to research that seeks to improve patient outcomes and push the boundaries of medical science.

Collaborations

At Cardiome Pharma Corp., Bertrand collaborates with talented professionals, including his coworkers Doug Ta Hung Chou and Peter Pang. Together, they work towards pioneering advancements in their respective fields, fostering an environment of innovation and collaborative success.

Conclusion

Bertrand MC Plouvier's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent on deuterated aminocyclohexyl ether compounds not only highlights his creativity but also underscores the importance of collaboration in achieving groundbreaking advancements. As he continues his research and development efforts, it will be exciting to see how his contributions will further impact the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…